Ditchcarbon
  • Contact
  1. Organizations
  2. Boehringer Ingelheim
Public Profile
Medical Device Manufacturing
DE
updated 20 days ago

Boehringer Ingelheim Sustainability Profile

Company website

Boehringer Ingelheim, a leading global pharmaceutical company, is headquartered in Ingelheim am Rhein, Germany. Founded in 1885, the company has established a strong presence in the healthcare industry, focusing on human pharmaceuticals, animal health, and biopharmaceutical contract manufacturing. With a commitment to innovation, Boehringer Ingelheim is renowned for its core products, including treatments for respiratory diseases, cardiovascular conditions, and diabetes management. The company’s dedication to research and development has led to significant milestones, positioning it among the top pharmaceutical firms worldwide. Notable achievements include a robust pipeline of novel therapies and a strong market presence in Europe, North America, and Asia. Boehringer Ingelheim continues to enhance its reputation through its unique approach to healthcare solutions, prioritising patient needs and sustainable practices.

DitchCarbon Score

How does Boehringer Ingelheim's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

34

Industry Average

Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Boehringer Ingelheim's score of 34 is higher than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.

57%

Let us know if this data was useful to you

Boehringer Ingelheim's reported carbon emissions

In 2023, Boehringer Ingelheim reported global carbon emissions of approximately 295,000,000 kg CO2e for Scope 1 and about 66,000,000 kg CO2e for Scope 2. The company has set ambitious targets to reduce its greenhouse gas emissions, committing to a 58.9% reduction in absolute Scope 1 and 2 emissions by 2030, using 2019 as the base year. Additionally, Boehringer Ingelheim aims for a 27.5% reduction in absolute Scope 3 emissions, which encompass emissions from purchased goods and services, capital goods, and other related activities, within the same timeframe. In the UK, for 2022, Boehringer Ingelheim's emissions were reported at approximately 1,116,000 kg CO2e, with Scope 1 emissions at about 655,000 kg CO2e and Scope 3 emissions at around 461,000 kg CO2e. The company has disclosed emissions data across all three scopes, demonstrating a comprehensive approach to its climate commitments. Boehringer Ingelheim's targets are aligned with the Science Based Targets initiative (SBTi), ensuring that their reduction goals are consistent with the global aim to limit warming to 1.5°C. The company’s emissions data is cascaded from its parent organization, Boehringer Ingelheim GmbH, reflecting a unified corporate strategy towards sustainability and climate action.

Unlock detailed emissions data

Access structured emissions data, company-specific emission factors, and source documents

20192020202120222023
Scope 1
289,000,000
000,000,000
000,000,000
000,000,000
000,000,000
Scope 2
273,000,000
000,000,000
00,000,000
00,000,000
00,000,000
Scope 3
3,801,000,000
0,000,000,000
0,000,000,000
0,000,000,000
-

How Carbon Intensive is Boehringer Ingelheim's Industry?

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Boehringer Ingelheim's primary industry is Medical Device Manufacturing, which is very low in terms of carbon intensity compared to other industries.

How Carbon Intensive is Boehringer Ingelheim's Location?

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Boehringer Ingelheim is in DE, which has a medium grid carbon intensity relative to other regions.

Boehringer Ingelheim's Climate Goals (2030 & 2050)

Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.

Boehringer Ingelheim has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Compare Boehringer Ingelheim's Emissions with Industry Peers

Regeneron

US
•
Pharmaceutical Preparation Manufacturing
Updated 9 days ago

Gilead Sciences

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Fresenius Kabi Aktiengesellschaft

DE
•
Real estate services (70)
Updated about 2 months ago

Fresenius

DE
•
Medical, precision and optical instruments, watches and clocks (33)
Updated 1 day ago

VIVUS, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 2 months ago

Coherus BioSciences, Inc.

US
•
Pharmaceutical Preparation Manufacturing
Updated 17 days ago

Frequently Asked Questions

Common questions about Boehringer Ingelheim's sustainability data and climate commitments

Let us know if this data was useful to you

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v251119.3
[email protected]+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
UL Solutions verification badge
CDP logo
Gartner Cool Vendor 2025 badge
Available onAWS Marketplace logo
ProductPortalScope 3 Tool FunctionalityDataIntegrationsPricing
CustomersHaleonGrant ThorntonHikmaRead all stories
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesCalculation MethodologyDocumentationBlogFAQOrganizationsIndustriesSBTI APITrust CentreChangelog
AboutTeamCareersLicense AgreementPrivacy